$50 million to be spent on research

Pfizer Australia, headquartered at West Ryde, will spend more than $50 million, in 2008, on R&D programs. In addition to supporting numerous pre-clinical programs and over 70 clinical research programs, Pfizer will provide more than $3 million in research grants and fellowship support to Australia's outstanding academics and clinicians. Pfizer employs more than 1500 staff. Current annual exports from its three manufacturing plants have an Australian market value in excess of $100 million. Pfizer’s history in Australia dates back to 1886.